Varicella seroprevalence in a random sample of the Turkish population

Basit Öğe Kaydı
dc.authoridDündar, Cihad/0000-0001-9658-2540
dc.authoridUlukol, Betul/0000-0001-8058-0911
dc.authorwosidDündar, Cihad/A-1148-2013
dc.contributor.authorKanra, G
dc.contributor.authorTezcan, S
dc.contributor.authorBadur, S
dc.date.accessioned2024-06-12T11:17:02Z
dc.date.available2024-06-12T11:17:02Z
dc.date.issued2002
dc.departmentTrakya Üniversitesien_US
dc.description.abstractChicken pox highly contagious and common throughout the world, is an infectious disease caused by varicella zoster virus (VZV). This study was conducted to determine the seroprevalence of VZV in a population under age 30 and to identify the relationship of VZV seroprevalence and several characteristics of the study subjects in nine provinces of Turkey. The sampling method of 30 clusters recommended for field studies was used for selecting subjects of a pre-determined number in the rural and urban areas in each province. For this, a total of 60 groups, 30 clusters in the rural and 30 in the urban areas were determined. It was planned that a total of 4800 subjects, including 600 subjects from five big provinces (Istanbul, Ankara, Izmir, Adana, Diyarbakir) and 450 subjects from the remaining smaller provinces (Samsun, Erzurum, Trabzon, Edirne), be included in the study. ELISA method was used to examine the blood samples for VZV seropositivity. Positive VZV seroprevalence was detected in 77.8% of 4387 subjects under age 30 in nine provinces of Turkey. There was no difference in seroprevalence rate between rural and urban areas. Seroprevalence was found to be 79.0% in urban areas and 76.3% in rural areas. Seroprevalence increased with age. Seroprevalence was 20% at the age of 1 year, subsequently increased to 40% at the age of 4 years, 60% at the age 6 years, 80% at the age of 8 years, 85% at the age of 10 years, and then remained at 85-90% in subjects over the age of 10 years. In order to develop vaccination protocols and take appropriate preventive health care measures against diseases in different countries, it is very important to know the seroprevalence of any disease for an individual country. (C) 2002 Elsevier Science Ltd. All rights reserved.en_US
dc.identifier.doi10.1016/S0264-410X(01)00459-5
dc.identifier.endpage1428en_US
dc.identifier.issn0264-410X
dc.identifier.issue9-10en_US
dc.identifier.pmid11818162en_US
dc.identifier.scopus2-s2.0-0037203853en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage1425en_US
dc.identifier.urihttps://doi.org/10.1016/S0264-410X(01)00459-5
dc.identifier.urihttps://hdl.handle.net/20.500.14551/24552
dc.identifier.volume20en_US
dc.identifier.wosWOS:000173858300019en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherElsevier Sci Ltden_US
dc.relation.ispartofVaccineen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectVaricellaen_US
dc.subjectSeroprevalanceen_US
dc.subjectVaccineen_US
dc.subjectZoster Virusen_US
dc.subjectSeroepidemiologyen_US
dc.subjectChildrenen_US
dc.titleVaricella seroprevalence in a random sample of the Turkish populationen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu